"The proceeds of the SIO Facility will provide funds for Admedus to fund general workingcapital and operational costs.
In addition, the Company will continue with the restructure ofthe business’ operations to reduce certain overhead costs, and a proposed divestment of theinfusion business so as to capitalise on its growing ADAPT® business."
Ann: Facility Agreement with SIO Partners LP, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.92 |
Change
-0.110(2.19%) |
Mkt cap ! $76.28M | |||
| Open | High | Low | Value | Volume |
| $4.94 | $5.18 | $4.92 | $127.3K | 25.62K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9984 | $4.92 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.10 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2025 (20 minute delay) ? |
| AVR (ASX) Chart |